Kerato Limited is a North-East England based biotech company developing innovative bioengineered corneal tissue products for medical, commercial and research applications.
Our team includes world leading academic experts in tissue engineering with commercial operational expertise.
Kerato uses cells and collagen to produce corneas in the laboratory that are comparable to those of human donors. The Company has a dedicated commercial team and has recently appointed a Managing Director, Sarah Greenhalgh, to oversee the development of product offerings and the execution of the product and sales strategy.
Our parent company is BSF Enterprise, and, with our fellow portfolio companies including 3D Bio-Tissues, we are working to support their vision of unlocking the next generation of biotech solutions.